Spinouts are in line to receive a share of the government funding to advance quantum applications spanning computing, imaging, sensors and communications.
Woodford Investment Management has reportedly disposed of its stakes in IP Group and Allied Minds, as its scramble to meet regulatory thresholds and redemption demands from investors in its Equity Income fund gathers pace.
Third Rock’s fifth vehicle will bid to form and invest in more promising biotech ventures to follow the likes of multiple spinouts, such as Johns Hopkins' Thrive Earlier Detection.
Deerfield Management and Columbia University have launched a $130m commercialisation fund, Hudson Heights Innovation, to support the university's early-stage biomedical research.
Fond Of’s co-founders have put $3.5m into High-Tech Gründerfonds’ third fund, bringing its total to $375m and adding to commitments from limited partners including Fraunhofer Society.
Fund manager Neil Woodford has sold his entire stake in Oxford Sciences Innovation, worth close to $70m, as his funds have come under increasing pressure.
Redbud Capital is among the limited partners in Longwater Investment’s advanced materials-focused fund, which also features several corporates.
Steady is the assessment that comes to mind, rather than remarkable, when probing the year-on-year direction of corporate venture capital investment in university spinouts.
WyoVentures will allow University of Wyoming to manage VC funds while also acting as a conduit to startups from the local ecosystem.
The intermediary close of PSL's deep tech-oriented fund comes after additional contributions from the EIF, Bpifrance and Vilmorin & Cie.